CytoDyn Inc. (CYDY)
OTCMKTS
· Delayed Price · Currency is USD
0.2350
-0.0040 (-1.67%)
Mar 28, 2025, 3:43 PM EST
CytoDyn Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
9
Market Cap
288.56M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCytoDyn News
- 11 days ago - March 2025 Letter to Shareholders - GlobeNewsWire
- 4 weeks ago - CytoDyn Announces Promising Survival Observations in mTNBC Patients Treated with Leronlimab - GlobeNewsWire
- 7 weeks ago - CytoDyn Announces Findings of Statistically Significant Fibrosis Reversal Across Studies with SMC Laboratories - GlobeNewsWire
- 3 months ago - December 2024 Letter to Shareholders - GlobeNewsWire
- 5 months ago - CytoDyn Phase 2 study of leronlimab cleared by FDA - Seeking Alpha
- 5 months ago - CytoDyn Announces FDA Clearance of Its Phase II Oncology Trial - GlobeNewsWire
- 5 months ago - CytoDyn Appoints Dr. Melissa Palmer, M.D., as Lead Consultant in Hepatology; Announces Follow-Up Inflammation Studies with SMC Laboratories - GlobeNewsWire
- 6 months ago - CytoDyn Announces Abstract that Highlights Leronlimab's Potential in Mediating ART-Free Viral Control in Infant Rhesus Macaques - GlobeNewsWire